Search
Pharming Group NV
PHARAdd to Watchlist
12.874USD
+0.080+0.62%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
6
analysts
Strong Buy
Current Rating
2.212
Target Price
-82.81%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Pharming Group NV
PHAR
6
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is the analyst rating for Pharming Group NV?
Based on the ratings of Pharming Group NV's stock from 6 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
